These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 16597469)

  • 1. The A/T-specific DNA alkylating agent adozelesin inhibits Plasmodium falciparum growth in vitro and protects mice against Plasmodium chabaudi adami infection.
    Yanow SK; Purcell LA; Spithill TW
    Mol Biochem Parasitol; 2006 Jul; 148(1):52-9. PubMed ID: 16597469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomic analyses of targeting the AT-rich malaria parasite genome with AT-specific alkylating drugs.
    Woynarowski JM; Krugliak M; Ginsburg H
    Mol Biochem Parasitol; 2007 Jul; 154(1):70-81. PubMed ID: 17524501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination with a Plasmodium chabaudi adami multivalent DNA vaccine cross-protects A/J mice against challenge with P. c. adami DK and virulent Plasmodium chabaudi chabaudi AS parasites.
    Scorza T; Grubb K; Cambos M; Santamaria C; Tshikudi Malu D; Spithill TW
    Int J Parasitol; 2008 Jun; 38(7):819-27. PubMed ID: 18062974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed parasite elimination in human infections treated with clindamycin parallels 'delayed death' of Plasmodium falciparum in vitro.
    Burkhardt D; Wiesner J; Stoesser N; Ramharter M; Uhlemann AC; Issifou S; Jomaa H; Krishna S; Kremsner PG; Borrmann S
    Int J Parasitol; 2007 Jun; 37(7):777-85. PubMed ID: 17280676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen-specific, interleukin 2-propagated T lymphocytes confer resistance to a murine malarial parasite, Plasmodium chabaudi adami.
    Brake DA; Weidanz WP; Long CA
    J Immunol; 1986 Jul; 137(1):347-52. PubMed ID: 2423609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin for malaria therapy.
    Reddy RC; Vatsala PG; Keshamouni VG; Padmanaban G; Rangarajan PN
    Biochem Biophys Res Commun; 2005 Jan; 326(2):472-4. PubMed ID: 15582601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmodium falciparum neutral aminopeptidases: new targets for anti-malarials.
    Skinner-Adams TS; Stack CM; Trenholme KR; Brown CL; Grembecka J; Lowther J; Mucha A; Drag M; Kafarski P; McGowan S; Whisstock JC; Gardiner DL; Dalton JP
    Trends Biochem Sci; 2010 Jan; 35(1):53-61. PubMed ID: 19796954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cleavage of DNA induced by 9-anilinoacridine inhibitors of topoisomerase II in the malaria parasite Plasmodium falciparum.
    Auparakkitanon S; Wilairat P
    Biochem Biophys Res Commun; 2000 Mar; 269(2):406-9. PubMed ID: 10708566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Plasmodium falciparum cGMP-dependent protein kinase (PfPKG): antiparasitic activity of a PKG inhibitor.
    Diaz CA; Allocco J; Powles MA; Yeung L; Donald RG; Anderson JW; Liberator PA
    Mol Biochem Parasitol; 2006 Mar; 146(1):78-88. PubMed ID: 16325279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of Plasmodium berghei parasitemia by LiCl in an animal infection model.
    Nurul Aiezzah Z; Noor E; Hasidah MS
    Trop Biomed; 2010 Dec; 27(3):624-31. PubMed ID: 21399604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced activity of mefloquine and artesunic acid against Plasmodium falciparum in vitro and P. berghei in mice by combination with ciprofloxacin.
    Andrade AA; de Pilla Varotti F; de Freitas IO; de Souza MV; Vasconcelos TR; Boechat N; Krettli AU
    Eur J Pharmacol; 2007 Mar; 558(1-3):194-8. PubMed ID: 17214980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmodium falciparum: growth response to potassium channel blocking compounds.
    Waller KL; Kim K; McDonald TV
    Exp Parasitol; 2008 Nov; 120(3):280-5. PubMed ID: 18703053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in vitro anti-plasmodial and in vivo anti-malarial efficacy of combinations of some medicinal plants used traditionally for treatment of malaria by the Meru community in Kenya.
    Gathirwa JW; Rukunga GM; Njagi EN; Omar SA; Mwitari PG; Guantai AN; Tolo FM; Kimani CW; Muthaura CN; Kirira PG; Ndunda TN; Amalemba G; Mungai GM; Ndiege IO
    J Ethnopharmacol; 2008 Jan; 115(2):223-31. PubMed ID: 18065175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug resistance is a component of V79 cell resistance to the alkylating agent adozelesin.
    Bhuyan BK; Smith KS; Kelly RC; Adams EG; Abraham I; Sampson KE
    Cancer Res; 1993 Mar; 53(6):1354-9. PubMed ID: 8443816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro assessment of the pharmacodynamic properties of DB75, piperaquine, OZ277 and OZ401 in cultures of Plasmodium falciparum.
    Hofer S; Brun R; Maerki S; Matile H; Scheurer C; Wittlin S
    J Antimicrob Chemother; 2008 Nov; 62(5):1061-4. PubMed ID: 18669520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A class of potent antimalarials and their specific accumulation in infected erythrocytes.
    Wengelnik K; Vidal V; Ancelin ML; Cathiard AM; Morgat JL; Kocken CH; Calas M; Herrera S; Thomas AW; Vial HJ
    Science; 2002 Feb; 295(5558):1311-4. PubMed ID: 11847346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmodium vivax: in vitro susceptibility of blood stages to synthetic trioxolane compounds and the diamidine DB75.
    Kocken CH; van der Wel A; Arbe-Barnes S; Brun R; Matile H; Scheurer C; Wittlin S; Thomas AW
    Exp Parasitol; 2006 Jul; 113(3):197-200. PubMed ID: 16458301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-plasmodial activity of the extracts of some Kenyan medicinal plants.
    Rukunga GM; Gathirwa JW; Omar SA; Muregi FW; Muthaura CN; Kirira PG; Mungai GM; Kofi-Tsekpo WM
    J Ethnopharmacol; 2009 Jan; 121(2):282-5. PubMed ID: 19041710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural regulatory (CD4+CD25+FOXP+) T cells control the production of pro-inflammatory cytokines during Plasmodium chabaudi adami infection and do not contribute to immune evasion.
    Cambos M; Bélanger B; Jacques A; Roulet A; Scorza T
    Int J Parasitol; 2008 Feb; 38(2):229-38. PubMed ID: 17868677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent antimalarial and transmission-blocking activities of centanamycin, a novel DNA-binding agent.
    Yanow SK; Purcell LA; Pradel G; Sato A; Rodriguez A; Lee M; Spithill TW
    J Infect Dis; 2008 Feb; 197(4):527-34. PubMed ID: 18275274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.